Advanced filters
News
AMO Pharma recently presented data from its trial investigating tideglusib (AMO-02) in teenagers…
News
Poor bone health is common in individuals with Duchenne muscular dystrophy. However, there is…
News
UPDATE (18/09/18): The researchers are still looking for volunteers for this study and have also…
News
We would like to invite you to take part in a study about anxiety in Duchenne muscular dystrophy.…
News
A recent preclinical study has identified a potential therapeutic target for Charcot Marie Tooth…
News
Dr Linda Popplewell and Professor George Dickson from Royal Holloway University took to Facebook…
News
The Human Fertilisation and Embryology Authority (HFEA) has given permission to doctors at the…
News
Acceleron Pharmaceuticals has announced preliminary results from its phase 2 trial testing ACE-083…
News
Summit Therapeutics has released interim results from their ongoing PhaseOut DMD study. The 48-week…
News
Today, the Committee for Medicinal Products for Human Use (CHMP) has returned a second negative…